Prescription drug prices in the United States have been a hot-button issue for decades. With nearly 25% of patients reporting they struggle to afford the prescription drugs they need, the issue is an important one. But the connection between drug prices and patient affordability is complex and often poorly understood. Groundbreaking ZS research provides a comprehensive view of what’s really happening with patient affordability and what politicians and the pharmaceutical industry miss when discussing this fraught topic.
During this webinar, we share insights from our research on the following topics:
- Identify the consequences of patient affordability and access issues
- Share ZS’s findings on the sources of patient affordability and how they differ from the public’s perception
- Discuss ways politicians and pharma companies could have a more productive dialogue on patient affordability issues